MoneyWorks4Me

A fair growth of 7.17% in the revenue at Rs. 19280.00 millions was reported in the September 2022 quarter as compared to Rs. 17990.00 millions during year-ago period.The Company's Net profit for the September 2022 quarter have declined marginally to Rs. 2720.00  millions as against Rs. 3260.00 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 6310.00 millions from 6710.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 19280.00 17990.00 7.17 38610.00 34940.00 10.50 67420.00 64510.00 4.51
Other Income 110.00 540.00 -79.63 400.00 1040.00 -61.54 2040.00 1180.00 72.88
PBIDT 6310.00 6710.00 -5.96 13250.00 12990.00 2.00 23040.00 23100.00 -0.26
Interest 620.00 640.00 -3.13 1130.00 1300.00 -13.08 2360.00 3340.00 -29.34
PBDT 5690.00 6070.00 -6.26 12120.00 11690.00 3.68 20680.00 19760.00 4.66
Depreciation 1560.00 1530.00 1.96 3050.00 3030.00 0.66 6020.00 6100.00 -1.31
PBT 4130.00 4540.00 -9.03 9070.00 8660.00 4.73 14660.00 13660.00 7.32
TAX 1410.00 1280.00 10.16 3080.00 2660.00 15.79 4750.00 2280.00 108.33
Deferred Tax 710.00 490.00 44.90 1520.00 1150.00 32.17 2220.00 -200.00 -1210.00
PAT 2720.00 3260.00 -16.56 5990.00 6000.00 -0.17 9910.00 11380.00 -12.92
Equity 1692.30 846.20 99.99 1692.30 846.20 99.99 846.20 846.20 0.00
PBIDTM(%) 32.73 37.30 -12.25 34.32 37.18 -7.69 34.17 35.81 -4.56
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..